Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-21.34	74.77	95.06
Graham Fair Price	26.15	18.83	14.93
PEG	-81.05	0.57	-3.01
Price/Book	3.91	6.23	6.00
Price/Cash Flow	-31.92	117.96	173.25
Prices/Earnings	-25.40	28.07	37.62
Price/Sales	12.33	17.00	15.14
Price/FCF	-31.92	117.96	173.25
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	7.38	0.46	0.43
Operating Margin	43.46	0.20	0.14
ROA	48.28	0.03	0.02
ROE	0.04	0.06	39.28
ROIC	0.03	0.04	43.17
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.15	0.08	83.80
Dividends QOQ	< 0.005	0.04	3290.07
EBIT QOQ	-0.16	0.41	165.07
EPS QOQ	-0.12	0.49	293.65
FCF QOQ	-0.41	0.62	50.74
Revenue QOQ	0.05	-0.02	-67.36
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	62.89	65.64	4.38
Days Sales Outstanding (DSO)	31.03	32.65	5.21
Inventory Turnover	1.43	1.37	-4.20
Debt/Capitalization	0.39	0.35	-9.52
Quick Ratio	0.61	0.78	26.89
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	15.76	16.85	6.89
Cash	1.41	1.44	2.01
Capex	-0.42	-0.19	54.38
Free Cash Flow	0.55	0.89	63.12
Revenue	6.25	6.18	-1.13
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.08	1.33	23.91
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	8.47	5.06	-40.18
Naive Interpretation	Member

06 - Financial Health · Weak

Rating